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abstract
 
We have explored whether 
 
 
 
-aminobutyric acid (GABA) is released by regulated exocytosis of GABA-
containing synaptic-like microvesicles (SLMVs) in insulin-releasing rat pancreatic 
 
 
 
-cells. To this end, 
 
 
 
-cells were
 
engineered to express GABA
 
A
 
-receptor Cl
 
 
 
-channels at high density using adenoviral infection. Electron micros-
 
copy indicated that the average diameter of the SLMVs is 90 nm, that every 
 
 
 
-cell contains 
 
 
 
3,500 such vesicles,
and that insulin-containing large dense core vesicles exclude GABA. Quantal release of GABA, seen as rapidly ac-
tivating and deactivating Cl
 
 
 
-currents, was observed during membrane depolarizations from 
 
 
 
70 mV to voltages
beyond 
 
 
 
40 mV or when Ca
 
2
 
 
 
 was dialysed into the cell interior. Depolarization-evoked GABA release was sup-
pressed when Ca
 
2
 
 
 
 entry was inhibited using Cd
 
2
 
 
 
. Analysis of the kinetics of GABA release revealed that GABA-
containing vesicles can be divided into a readily releasable pool and a reserve pool. Simultaneous measurements
of GABA release and cell capacitance indicated that exocytosis of SLMVs contributes 
 
 
 
1% of the capacitance sig-
nal. Mathematical analysis of the release events suggests that every SLMV contains 0.36 amol of GABA. We con-
clude that there are two parallel pathways of exocytosis in pancreatic 
 
 
 
-cells and that release of GABA may accord-
ingly be temporally and spatially separated from insulin secretion. This provides a basis for paracrine GABAergic
signaling within the islet.
 
key words:
 
GABA • GAD65 • pancreatic islets • paracrine communication • SLMV
 
INTRODUCTION
 
Type 1 diabetes mellitus is caused by the selective au-
toimmune destruction of insulin-producing 
 
 
 
-cells in
pancreatic islets of Langerhans. One of the most im-
portant autoantigens in type 1 diabetes is the 65-kD iso-
form of glutamate decarboxylase (GAD65). Antibodies
against GAD65 are formed in 75–84% of the patients
(Schmidli et al., 1994). GAD65-reactive cytotoxic T-lym-
phocytes can mediate the autoimmune destruction of
the 
 
 
 
-cells (Yoon et al., 1999). Despite the importance
of GAD65 in the disease process, its physiological role
in pancreatic islets is still unclear.
GAD65 and the second isoform of glutamate decar-
boxylase, GAD67, catalyze the formation of the inhibi-
tory neurotransmitter GABA from glutamate. Both
GAD and GABA are present in pancreatic islets at con-
centrations similar to those encountered in classical
GABAergic regions of the brain (Taniguchi et al.,
1977). In pancreatic islets, both GAD and GABA selec-
tively localize to 
 
 
 
-cells (Michalik and Erecinska, 1992).
While GABA has been ascribed an intracellular role as
a fuel in 
 
 
 
-cells (Sorenson et al., 1991), the ﬁnding of
inhibitory effects of exogenously added GABA on the
secretion of insulin (Shi et al., 2000), glucagon (Rors-
man et al., 1989), and somatostatin (Robbins et al.,
1981) suggested a putative function as a paracrine
transmitter. Indeed, GABA receptors have been dem-
onstrated in different cell types of pancreatic islets
(Rorsman et al., 1989; Yang et al., 1994; von Blanken-
feld et al., 1995).
Understanding the function of GABA as a paracrine
transmitter in islets requires information on how, if at
all, GABA is secreted from 
 
 
 
-cells and its regulation.
Studies on the release of GABA from 
 
 
 
-cells, however,
have so far yielded conﬂicting results (Ahnert-Hilger
and Wiedenmann, 1992; Smismans et al., 1997), which
may partially be due to the lack of an assay with high
temporal and quantitative resolution.
In 
 
 
 
-cells, GAD65 and GABA are excluded from
insulin-containing large dense-core vesicles (LDCVs)
(Garry et al., 1988) and are instead believed to princi-
pally associate with synaptic-like microvesicles (SLMVs)
(Reetz et al., 1991; Thomas-Reetz et al., 1993). SLMVs
share many protein components with synaptic vesicles
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of neurons and can be found in several endocrine cell
types (Thomas-Reetz and De Camilli, 1994). Classical
high-resolution techniques for monitoring exocytosis,
such as capacitance measurements, cannot readily dis-
tinguish between LDCVs and SLMVs. Indeed, it has
been proposed that an early rapid component of capac-
itance increase results from release of SLMVs (Taka-
hashi et al., 1997). We have developed a novel method
that allows the detection of individual GABA-contain-
ing vesicles at high temporal resolution. We show here
that GABA is promptly released by regulated Ca
 
2
 
 
 
-
dependent exocytosis during membrane depolariza-
tions to physiological voltages. This provides a basis
for paracrine intercellular signaling exerted by GABA
within the islet micro-organ.
 
MATERIALS AND METHODS
 
Adenovirus Construction
 
cDNAs encoding the GABA
 
A
 
 
 
1
 
 and the GABA
 
A
 
 
 
1
 
 subunits of the
human GABA
 
A
 
 receptor were subcloned into the shuttle vector
pACCMV.pLpA (Becker et al., 1994). The plasmids pACCMV-
GABA
 
A
 
 
 
1
 
 and pACCMV-GABA
 
A
 
 
 
1
 
 were cotransfected into
HEK293 cells together with pJM17 to obtain recombinant ade-
noviruses encoding either the GABA
 
A
 
 
 
1
 
 or the GABA
 
A
 
 
 
1
 
 recep-
tor subunits. Viral titres were determined by agarose overlay of
HEK293 cells (Becker et al., 1994).
 
Islet Cell Preparation and Infection
 
Pancreatic islets were isolated from Sprague-Dawley or Wistar
rats by collagenase digestion as described elsewhere (Olofsson et
al., 2002). All experiments involving animal experiments were
performed in accordance with the regulations of the ethical com-
mittee at Lund University. Single cells were prepared by tricula-
tion of islets in Ca
 
2
 
 
 
-free solution. The cells were coinfected with
the recombinant adenoviruses encoding the GABA
 
A
 
 
 
1
 
 and
GABA
 
A
 
 
 
1
 
 subunits (10–100 pfu/cell) and used for experiments
24–48 h after infection. In some initial experiments (Figs. 6 A
and 8), 20 mM of GABA was added to the culture medium to en-
sure that the GABA-containing vesicles are not depleted of
GABA; no difference in the properties of GABA release were de-
tected between the loaded and unloaded cells. It was ascertained
separately by immunogold electron microscopy that GABA did
not accumulate in insulin-containing LDCV during this proce-
dure (unpublished data).
 
Electrophysiology
 
Patch pipettes were pulled from borosilicate glass (tip resistance
3–6 M
 
 
 
). The electrophysiological measurements were con-
ducted using the perforated patch (Fig. 8) or standard whole-cell
conﬁguration (all other experiments). In the former type of re-
cordings, electrical contact was established by inclusion of the
pore-forming antibiotic amphotericin B into the pipette solution
(ﬁnal concentration: 0.24 mg/ml). The measurements were per-
formed using an EPC9 patch-clamp ampliﬁer (HEKA Electron-
ics) and Pulse software (version 8.31, HEKA). 
 
 
 
-cells were identi-
ﬁed based on their size and on the inactivation properties of volt-
age-gated sodium currents (Hiriart and Matteson, 1988; Göpel et
al., 1999).
For the recording of GABA-induced current transients, the
cells were normally held at 
 
 
 
70 mV and depolarizations were
 
500 ms long and went (unless otherwise indicated) to 0 mV. Exo-
cytosis was detected as changes in cell capacitance, which was
estimated by the Lindau-Neher technique implementing the
“Sine 
 
 
 
 DC” feature of the lock-in module of the Pulse software.
The amplitude of the sine wave was 20 mV and the frequency was
set to 500 Hz.
 
Photorelease of Caged Calcium
 
Photolysis of Ca
 
2
 
 
 
 nitrophenyl-EGTA was elicited by brief UV
light ﬂashes (
 
 
 
2 ms; XF-10, HiTech). Increases in intracellular
Ca
 
2
 
 
 
 were measured by dual wavelength spectroﬂuorimetry us-
ing the Ca
 
2
 
 
 
 indicator Fura FF (100 
 
 
 
M; Molecular Probes) in an
Ionoptix ﬂuorescence-imaging system equipped with the soft-
ware IonWizard (IonOptix). Concentrations of intracellular Ca
 
2
 
 
 
were calculated using a K
 
D
 
 of 35 
 
 
 
M for the Ca
 
2
 
 
 
–Fura FF com-
plex in the presence of Mg
 
2
 
 
 
. Initial [Ca
 
2
 
 
 
]
 
i
 
 was estimated to be
 
 
 
0.3 
 
 
 
M.
 
Solutions
 
The standard extracellular solution consisted of (in mM unless
stated otherwise) 118 NaCl, 20 TEACl, 5.6 KCl, 2.6 CaCl
 
2
 
, 1.2
MgCl
 
2
 
, 5 HEPES, and 5 glucose (pH 7.4 with NaOH). The pi-
pette solution for recording of currents evoked by external appli-
cation of GABA (Fig. 2, C and D) contained 125 CsCl, 30 CsOH,
10 EGTA, 1 MgCl
 
2
 
, 5 HEPES, and 3 Mg-ATP (pH 7.15 with HCl).
The intracellular medium used for the trains of depolarizations
(Figs. 5, A and B, and 7 A) contained 125 Cs
 
 
 
-glutamate, 10 CsCl,
10 NaCl, 1 MgCl
 
2
 
, 5 HEPES, 0.05 EGTA, 3 Mg-ATP, and 0.1 cAMP
(pH 7.15 with CsOH). For Ca
 
2
 
 
 
 infusion experiments (Figs. 3, 4,
and 6 B), the pipette solution consisted of 139 CsCl, 1 MgCl
 
2
 
, 5
HEDTA, 3 Mg-ATP, 0.1 cAMP, 5 HEPES (pH 7.15 with CsOH),
and 0.57 or 2.23 CaCl
 
2
 
 for free Ca
 
2
 
 
 
 concentrations of 3 
 
 
 
M or
25 
 
 
 
M, respectively. In the experiments involving photorelease
of caged Ca
 
2
 
 
 
 (Fig. 6 A), the pipette solution was composed of
110 CsCl, 10 KCl, 10 NaCl, 1 MgCl
 
2
 
, 25 HEPES (pH 7.1 with
KOH), 3 MgATP, 0.1 cAMP, 3 NP-EGTA (Molecular Probes), 2
CaCl
 
2
 
, and 0.1 fura-FF. In the perforated patch experiments (Fig.
8), the pipette solution contained 76 Cs
 
2
 
SO
 
4
 
, 10 KCl, 10 NaCl, 1
MgCl
 
2
 
, and 5 HEPES (pH 7.35 with CsOH; 297 mOsm after in-
clusion of amphotericin). For measurement of the voltage de-
pendence of GABA exocytosis (Fig. 7 B), the pipette solution
contained 145 CsCl, 1 MgCl
 
2
 
, 5 HEPES, 0.05 EGTA, 3 Mg-ATP,
and 0.1 cAMP (pH 7.15 with CsOH), and the extracellular solu-
tion was composed of 118 D-gluconic acid, 10 TEACl, 2.6 CaCl
 
2
 
,
1.2 MgCl
 
2
 
, 5 HEPES, 5 glucose, and 5.6 K
 
 
 
-glutamate or 2.8
K
 
2
 
SO
 
4
 
 (adjusted to pH 7.4 with NaOH). This combination of ex-
tra- and intracellular solutions had to be used in order to resolve
the GABA-activated Cl
 
 
 
 currents over a wide range of voltages.
Similar results were obtained with potassium glutamate and po-
tassium sulfate containing extracellular solutions. This indicates
that glutamate, e.g., via activation of ionotropic glutamate recep-
tors (Inagaki et al., 1995), did not affect the results in this series
of experiments. Data obtained under both conditions were
therefore combined. Liquid junction potentials (V
 
LJ
 
) were mea-
sured according to Neher (1992). V
 
LJ
 
 was 
 
 
 
4 mV for Na
 
 
 
-glucon-
ate containing bath solution versus CsCl containing pipette solu-
tion (Fig. 7 B) and 
 
 
 
15 mV for the standard extracellular solu-
tion versus the Cs
 
 
 
-glutamate containing pipette solution (Figs.
5, A and B, and 7 A). V
 
LJ
 
 were not corrected for in the experi-
ments shown.
 
Western Blotting
 
Islet homogenates were separated by SDS/PAGE on 8% acryl-
amide gels and transferred onto polyvinyldiene diﬂuoride 
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(PVDF) membranes. The membranes were incubated overnight
with anti-GABA
 
A
 
 
 
1
 
 (Chemicon, 1:100), followed by horseradish-
peroxidase (HRP)-coupled secondary antibody (1:20,000 dilu-
tion; Pierce Chemical Co.) for 1 h. The blots were developed
by using SuperSignal
 
®
 
 West Pico Chemiluminiscent Substrate
(Pierce Chemical Co.) and visualized on X-ray ﬁlms.
 
Immunocytochemistry
 
Rat islet cells were ﬁxed using the formaldehyde-pH-shift
method and permeabilized with 0.2% Triton. Nonspeciﬁc bind-
ing was blocked with 4% normal donkey serum. The cells were
incubated overnight at 4
 
 
 
C with anti-insulin (1:1000; Eurodiag-
nostica) and anti-GABA (Sigma-Aldrich, 1:2,000; Fig. 1 C) or
anti-GABA
 
A
 
 
 
1
 
 (Chemicon, 1:100; Fig. 2 B) antibodies. This was
followed by incubation for 1 h with the corresponding secondary
antibodies coupled to Cy5 and Cy2 (1:150; Jackson ImmunoRe-
search Laboratories), respectively. Fluorescence was visualized
using a Plan-Apochromat 100
 
 
 
/1.4 oil objective and the 488 nm
(Cy2) and 633 nm (Cy5) lines of a ZEISS LSM 510 confocal mi-
croscope. Images were acquired using ZEISS LSM 510 software.
 
Electron Microscopy
 
For detailed ultrastructural analysis, islets were prepared and an-
alyzed as described elsewhere for mouse islets (Olofsson et al.,
2002). For immunogold electron microscopy, intact pancreatic
islets were ﬁxed in 1% paraformaldehyde and 2.5% glutaralde-
hyde for 1 h at 4
 
 
 
C. After ﬁxation, the islets were washed with
PBS, embedded in agarose (type VII, Sigma-Aldrich), cryopro-
tected in glycerol, and embedded in Lowicryl HM20 by cryoﬁx-
ation and freeze-substitution. Immunoreactivity was detected by
postembedding immunogold labeling of ultrathin sections (60–
80 nm) using a rabbit anti-GABA primary antibody (Chemicon
AB5016) and a goat anti–rabbit secondary antibody conjugated
to 15-nm gold particles (Amersham Biosciences). Background
staining over empty resin amounted to 2   1 particles/ m2 and
has not been subtracted. Speciﬁcity of immunolabeling was mon-
itored by parallel processing of test sections containing amino
acid–glutaraldehyde brain macromolecule conjugates (GABA,
glutamate, taurine, glycine, aspartate, glutamine, or in the ab-
sence of any amino acid). Quantitative analysis of these test sec-
tions demonstrated dense staining of the GABA conjugate and
absence of signiﬁcant cross-reactivity with the other conjugates.
Estimation of Vesicular GABA Content
After fusion of a vesicle with the plasma membrane, GABA dif-
fuses into the surrounding solution and activates GABAA recep-
tor Cl  channels. This causes a transient increase in an ion cur-
rent across the plasma membrane. The size of the current  I
through an elementary surface  S at an arbitrary time moment
after the fusion event depends on the local concentration of
GABA, on the density and conductance of the GABAA receptor
Cl  channels and their binding afﬁnity. Therefore it may be ex-
pressed mathematically in the following form:
(1)
where   is a proportionality coefﬁcient comprising the surface
density of the GABAA receptor and its single-channel conduc-
tance and p(c) is the dose–response function that shows the pro-
portion of channels that are open at GABA concentration equal
to c. The total current at the same moment is then obtained by
integrating the Eq.1 over the surface of the plasma membrane S
and is equal to
∆I αpc () ∆ S, =
(2)
The local concentration of GABA c at a given time point de-
pends on the initial concentration in the vesicle c0, the diameters
of the vesicle and the fusion pore and the diffusion coefﬁcient of
GABA in the vesicle and surrounding medium. Since after the
opening of a fusion pore GABA rapidly diffuses into the sur-
rounding space, the total current I is a peak function of time.
This function was used to ﬁt an experimental current peak
caused by the release of GABA from a fused vesicle with the ini-
tial concentration of GABA in vesicle c0 as the main ﬁtting param-
eter. To solve the diffusion problem, the software package FEM-
LAB (Comsol) was used. The obtained solution was then im-
ported into the MATLAB workspace (Mathworks, Inc.) and used
for ﬁtting to experimental data.
Analysis and Statistical Evaluation
Data are given as mean   SEM. Statistical signiﬁcances were eval-
uated using Student’s t test. The GABA-induced current tran-
sients were analyzed using the software MiniAnalysis (Synap-
tosoft). In experiments with high release rates and signiﬁcant
overlap of the current transients, the number of release events
was estimated by dividing the total charge of the GABAA recep-
tor–mediated Cl  currents by the charge of an averaged quantal
response from the same experiment. In experiments with lower
release rates and apparently well separated individual current
transients, the number of events was determined directly by
counting.
RESULTS
Ultrastructural Analyses of LDCVs and SLMVs in Rat 
Pancreatic Islets
Fig. 1 A shows an electron micrograph of a rat pancre-
atic islet illustrating the presence of both SLMVs (white
arrows) and LDCVs (black arrows) in  -cells. The histo-
gram in Fig. 1 B shows the measured proﬁle diameters.
It is clear that the vesicles diameters fall in two distinct
classes that can both be described by Gaussian distribu-
tions. The true vesicle diameters were derived from the
observed proﬁle diameter distribution as described
previously (Olofsson et al., 2002). We thus estimated
the average diameters of the SLMVs and LDCVs to be
91   4 nm (n   688 in 83 cells) and 327   6 nm (3,515
in 83 cells), respectively. The value for SLMVs is equal
to that obtained in chromafﬁn cells (Plattner et al.,
1997). The coefﬁcients of variation (CV; standard devi-
ation relative to mean value) were 0.27 and 0.22 for
SLMVs and LDCVs, respectively. The total number of
SLMVs was 3,460   135 (n   83) per  -cell, of which
238   33 (n   83) were docked with the plasma mem-
brane (examples of docked SLMVs highlighted by
white arrows in Fig. 1 A). The corresponding values for
the LDCVs in rat  -cells were 10,047   435 and 450  
42 per cell. The number of LDCVs in rat  -cells in good
agreement with previous estimates in mouse  -cells
(Dean, 1973; Olofsson et al., 2002).
Immunocytochemistry conﬁrmed that GABA is stored
in the  -cells and revealed that the concentrations var-194 GABA Exocytosis in Pancreatic  -cells
ied considerably from cell to cell (Fig. 1 C). This corre-
lated with varying levels of GAD65 expression (unpub-
lished data). Immunogold electron microscopy was per-
formed on  -cells in intact islets using a GABA-speciﬁc
antibody (Fig. 1 D). The particle density measured
within the insulin-containing LDCVs and the remainder
of the cell were 5.7   3.2 and 30   19 particles/ m2, re-
spectively. This shows that GABA is excluded from
LDCVs. Because of the low contrast inherent to the im-
munogold technique, it was not possible to demonstrate
the accumulation of GABA in SLMVs directly.
Detection of Quantal GABA Release
To measure GABA secretion from single  -cells, we de-
veloped a novel assay based on the overexpression of
GABAA receptor Cl  channels in isolated pancreatic is-
let cells. To this end, adenoviral vectors encoding for
the  1 and  1 subunits of the human GABAA receptor
(Birnir et al., 1995), respectively, were constructed and
used to coinfect freshly isolated rat pancreatic  -cells.
Western blot analysis revealed  20-fold overexpression
of GABAA receptors compared with noninfected islets
(Fig. 2 A). Immunocytochemistry showed homogenous
distribution of the receptor in the plasma membrane
(Fig. 2 B). Electrophysiological measurements were
performed on single infected  -cells. Application of
GABA (1 mM) to the bath solution evoked an inward
current in  80% of the cells (Fig. 2 C). The current
typically had an amplitude between 0.5 and 2 nA and
was half-maximally activated by 30  M GABA (Fig. 2
D). No GABA-activated current was observed in nonin-
fected  -cells. This does not mean, however, that all is-
let cells lack GABAA-receptors. We have previously dem-
onstrated in guinea pig that glucagon-producing  -cells
contain such receptors at high density (Rorsman et al.,
1989) and unpublished data indicate that this is also
the case in rat islets.
We reasoned that if GABA is released by exocytosis of
GABA-containing SLMVs in  -cells engineered to over-
express GABAA-receptor Cl -channels, then release of
the neurotransmitter should be detectable as an in-
creased Cl -conductance. Fig. 3 A shows a whole-cell
patch-clamp recording from a  -cell infused with pi-
pette solution containing 3  M free Ca2 . The holding
potential was  70 mV. Superimposed on the back-
ground current are discrete, transient inward current
spikes resembling inhibitory postsynaptic currents
(IPSCs) in neurons (Edwards et al., 1990). The tran-
sient currents were completely and reversibly blocked
by 100  M of the GABAA receptor antagonist bicu-
culline (Fig. 3 B; n   4). We conclude that the transient
currents described above are attributable to activation
of GABAA-receptor Cl  channels after exocytosis of sin-
gle GABA-containing vesicles from  -cells.
Characteristics of Currents Triggered by GABA Release
The amplitude of the transient currents elicited upon
stimulation of exocytosis with high intracellular Ca2 
Figure 1. Localization of
GABA and  -cell ultrastruc-
ture. (A) Electron micro-
graph of a rat pancreatic
islet. Three docked insu-
lin-containing LDCVs and
two docked GABA-containing
SLMVs have been high-
lighted by the black and white
arrows, respectively. Bar, 250
nm. (B) Diameters of SLMVs
and LDCVs in rat pancreatic
 -cells. Two Gaussians have
been approximated to the
distribution of the proﬁle di-
ameters of the SLMVs and
LDCVs. (C) Immunoﬂuores-
cence micrograph of  -cells
maintained in tissue culture
for 24 h using speciﬁc anti-
bodies against insulin (red,
left) and GABA (green,
right). Note the low GABA
content of some  -cells (indi-
cated by arrows). Bar, 5  m.
(D) Immunogold labeling of
GABA in a  -cell in an intact
islet. Bar, 500 nm.195 Braun et al.
was very variable (Fig. 4 A). The transient currents acti-
vated in 12.6   0.7 ms (10–90% rise time) and had a
half width (i.e., the time the current exceeds 50% of
the peak amplitude) of 30   1 ms (n   117). Neither
of these parameters showed any dependence on the
current amplitude (Fig. 4, A–C). The average ampli-
tude of the transient currents in this experiment was
38   2 pA (range 10–141 pA; n   117). In the same
cell, application of 1 mM GABA to saturate the recep-
tors elicited a whole-cell current of 1.7 nA, suggesting
that an individual GABA release event activates only
 2% of the GABAA receptors.
The amplitude of the GABA-induced current tran-
sients is likely to be proportional to the GABA content
of the vesicles undergoing exocytosis. Given that the
vesicle diameters (d) are normally distributed (Fig. 1
B), we predict that the cubic roots of the current ampli-
tudes ( ) should also be normally distributed if the
vesicles are uniformly loaded with GABA (remember
that vesicle volume (V) is given by the expression
I 3
). As shown in Fig. 4 D, the distribution of
 can be described by a single Gaussian (continuous
curve superimposed on histogram) with a CV of 0.32.
The latter value is reasonably close to that obtained for
the vesicle diameter (0.27; see above). The histogram
further suggests that  20% of the events were below
the detection threshold of  10 pA.
Collectively, the analysis of the transient currents sug-
gests that they arise from exocytosis of a single popula-
tion of GABA-containing vesicles. Given that the insu-
lin-containing LDCVs exclude GABA, it seems justiﬁ-
able to conclude that the observed events result from
exocytotic fusion of GABA-containing SLMVs. Qualita-
tively similar results were obtained in three additional
experiments analyzed the same way.
Estimation of the Intravesicular GABA Concentration
We estimated the intravesicular concentration of GABA
by mathematical modelling of an averaged current
spike from the experiment in Figs. 3 A and 4, A–D. The
V 4
3
---πr
3 =
I 3
Figure 2. Overexpression of GABAA
receptors in  -cells. (A) Western blot of
homogenates of rat islet cells ( 150 is-
lets) infected or not with the adenoviral
constructs encoding the GABAA-recep-
tor Cl  channels, using an antibody
against the  1 subunit (top), and the
corresponding densitograms (below).
The bands in the noninfected samples
may correspond to endogenous  1 sub-
units in non- -cells. (B) Immunoﬂuo-
rescence micrograph of a  -cell in-
fected with the adenoviral constructs us-
ing antibodies against the  1 subunit of
the GABAA receptor (green) and insu-
lin (red). Bar, 5  m. (C) Inward current
activated in an infected  -cell by rapid
application of GABA (1 mM) to the
bath solution. (D) Relationship be-
tween the GABA concentration and the
peak amplitude of the Cl -current re-
sponses. The current responses have
been normalized to the maximum peak
current (usually observed in response
to 1 mM GABA). All concentrations
were tested in the same cell. Data are
mean values   SEM of ﬁve experi-
ments. The Hill equation was approxi-
mated to the data points giving a Kd of
30  M.196 GABA Exocytosis in Pancreatic  -cells
GABAA receptor–mediated conductance per area, cor-
responding to the proportionality coefﬁcient   in Eqs.
1 and 2 (see materials and methods), was measured
by application of a saturating concentration of GABA at
the end of the experiment in combination with the esti-
mation of the cell surface by capacitance measure-
ments. The dose–response curve was obtained from
Fig. 2 D. The SLMV diameter was taken to be 90 nm
(Fig. 1 B), the membrane thickness to be 7 nm, and the
fusion pore diameter was assumed to be 3 nm (Albillos
et al., 1997). As shown in Fig. 4 E, the model reasonably
predicts the time-course and amplitude of the current
transient. We thus estimated that every vesicle contains
0.36 amol of GABA, which corresponds to an intravesic-
ular concentration of 0.9 M.
GABA Release during Trains of 
Voltage-clamp Depolarizations
We next investigated GABA release during depolariza-
tions to 0 mV from a holding potential of  70 mV. The
depolarizations are expected to open voltage-gated
Ca2  channels, thus elevating the intracellular Ca2  lev-
els. Trains of 10 depolarizations (500 ms) were applied
at 1 Hz to infected cells infused with Ca2 -free solution
containing 50  M EGTA. As shown in Fig. 5 A, the de-
polarizations triggered transient currents similar to
those described above. The inset shows the current re-
sponses elicited by the fourth pulse (dotted rectangle)
on an expanded time base. The direction of the cur-
rents is outward rather than inward during the depolar-
izations to 0 mV as the equilibrium potential of Cl 
with the solutions used (152 mM Cl  in the extracellu-
lar, 23 mM Cl  in the intracellular solution) is  49 mV.
By analogy to what was seen in the intracellular dialysis
experiments (Fig. 3 B), the current transients that
could be elicited by membrane depolarization were
completely blocked by addition of the GABAA receptor
antagonist bicuculline (100  M) to the bath solution
(n   8; unpublished data).
Exocytosis of SLMVs Contributes Little to
Capacitance Increases
Cell capacitance is a powerful single-cell assay of secre-
tion that monitors changes of cell-surface area due to
exocytotic fusion of vesicles with the plasma membrane
(Moser and Neher, 1997). The magnitude of the capac-
itance increase ( Cm) resulting from the fusion of a
vesicle with the plasma membrane is proportionally re-
lated to the square of the vesicle radius (r; i.e.,  Cm  
  r2 where   is 9 fF/ m2). Exocytosis of an SLMV (r  
45 nm; Fig. 1 B) and an LDCV (r   164 nm) can ac-
cordingly be expected to result in a capacitance in-
crease of 0.23 and 3.4 fF, respectively. We combined ca-
pacitance measurements with our single-vesicle assay of
GABA/SLMV release. In the experiment shown in Fig.
5 A, the train of depolarizations elicited a capacitance
increase of 546 fF. Because of the comparatively high
exocytotic rate in this experiment, causing signiﬁcant
overlap of the GABA-induced current transients, the
number of current transients was estimated by dividing
the total charge of the GABA-induced current through
the charge of an average single event. We thereby esti-
mated that the train triggered 52 current transients.
From these data it can be calculated that exocytosis of
SLMVs in this experiment accounts for  2% of the
measured capacitance increase (i.e., 52   0.23 fF/546
fF). In a series of 11 experiments, the capacitance in-
crease per current transient averaged 31   6 fF, corre-
sponding to a contribution of SLMV exocytosis to the
capacitance signal of  0.7% (0.23 fF/31 fF). It there-
Figure 3. Quantal release of GABA. (A) Current trace (overlay
of six sweeps) from an infected  -cell infused with pipette solution
containing 3 mM free Ca2  at  70 mV holding potential. Cl  cur-
rent spikes, corresponding to spontaneous release of GABA-con-
taining vesicles, are superimposed on the background current. (B)
Recording from another cell under the same experimental condi-
tions as in A before (top) and after (middle) addition of the
GABAA receptor antagonist bicuculline to the bath solution and af-
ter washout of the antagonist (bottom; each trace corresponds to
ﬁve superimposed sweeps).197 Braun et al.
fore seems justiﬁable to conclude that capacitance
measurements in  -cells primarily reﬂect exocytosis of
insulin-containing LDCVs. We acknowledge, however,
that because of the amplitude distribution and thresh-
olding, we will miss some GABA-induced events (see
above). Even when allowance is made for this, it is clear
that the frequency of the GABA-activated current tran-
sients is only  10% of that expected if they were due to
LDCV exocytosis.
The experiment in Fig. 5 A also revealed a progres-
sive decrease in the number of current transients trig-
gered by the later depolarization pulses of the train.
Eventually, some pulses (numbers 8 and 10) failed to
evoke any GABA release. Fig. 5 B summarizes data from
ﬁve cells. During the ﬁrst train (black columns), the to-
tal number of events elicited averaged 8.2   2.5 per
train. It is evident that there is a  75% decline in the
release probability during the train. In contrast, the
voltage-gated Ca2  currents decreased only by 23   3%
between the ﬁrst and tenth pulse of the depolarization
train (n   13; unpublished data). When another train
of depolarizations was applied 2 min later, the release
probability during the initial part of the train was al-
most restored to that observed during the ﬁrst train
(white columns; total number of events 7.5   2.5 per
train; n   5).
Ca2  Dependence of GABA Release
The fact that exocytosis of GABA can be triggered by
membrane depolarization suggests that it may be trig-
gered by an increase in the cytoplasmic-free Ca2 -
concentration. We explored the Ca2  dependence of
GABA exocytosis from  -cells by loading infected
 -cells via the patch pipette with “caged-Ca2 ” (Ca2 -
NP-EGTA). Photolysis of the compound by a ﬂash of
UV-light led to an instantaneous increase of the intra-
cellular Ca2  concentration (Fig. 6 A, bottom). This trig-
gered both an increase in cell capacitance (middle)
Figure 4. Properties of quantal GABA release.
(A, left) Two transient currents illustrating the
variability of the current amplitudes. (Right) Am-
plitude-corrected overlay the ﬁrst (red) and sec-
ond (black) transient current from the left panel,
demonstrating the similarity in current kinetics.
(B) Rise time (10–90%) displayed against current
amplitude. (C) Duration (half widths) of current
transients displayed against current amplitude.
For display purposes, the data presented in B an
C are presented as mean values   SEM of 10 am-
plitude-matched responses. (D) Distribution of
the cubic roots of transient current amplitudes
( ) of the same events as in those presented in
A–C. A Gaussian ﬁt is superimposed (N   num-
ber of events). (E) Experimentally measured
GABA-activated Cl -current transient (mean of 12
events; continuous line) and current response ob-
tained by mathematical modelling (circles).
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and a series of transient currents reﬂecting exocytosis
of GABA-containing vesicles (top). The increase in ca-
pacitance per current transient averaged 26   5 fF
(n   5). This conﬁrms the results obtained with mem-
brane depolarizations (Fig. 5 A) that release of GABA
via exocytosis of SLMVs accounts for  1% of the capac-
itance increase (0.23 fF/26 fF). The dissociation of
GABA release and capacitance increase seen in this ex-
periment (the six rightmost events in Fig. 6 A, top)
could be the consequence of either these release events
adding very little membrane area (equivalent to 6  
0.23 fF   1.3 fF) or concomitant endocytosis masking
ongoing exocytosis (Eliasson et al., 1996).
To further quantify the Ca2  dependence of GABA
exocytosis, we compared GABA release from  -cells in-
fused with pipette solution containing 3  M (Fig. 6 B,
top) or 25  M (bottom) free Ca2  in the standard
whole-cell conﬁguration. As the current transients usu-
ally appeared clearly separated in these experiments,
the number of events was determined directly by count-
ing. At 3  M free Ca2 , 9.4   3.2 events/min were ob-
served (n   9), whereas at 25  M free Ca2  the fre-
quency increased to 20.3   4.4 events/min (P   0.05;
n   9). In the same experiments, a similar  2-fold dif-
ference between the lower and higher Ca2  concentra-
tion was measured for the rate of capacitance increase;
349   130 fF/min at 3  M and 758   168 fF/min at 25
Figure 5. Depolarization-induced exocytosis. (A) Transient Cl 
currents (bottom) and increase in cell capacitance (middle) trig-
gered by a train of ten 500-ms depolarizations from  70 to 0 mV
in an infected  -cell. (Inset) A part of the recording (marked by
the dashed box) on an expanded time base, including ﬁve tran-
sient Cl  currents. Note that the driving force for Cl  ions is in-
ward (corresponding to an upward deﬂection of the current
trace) at 0 mV and outward at  70 mV with the solutions used.
While some transient currents were observed between the depolar-
ization pulses, no events were observed before the train. (B) Num-
ber of Cl  current transients (N) elicited by the individual depolar-
ization pulses during trains of 10 500-ms depolarizations from  70
to 0 mV during a ﬁrst train (black bars) and a second train applied
2 min later (white bars, n   5).
Figure 6. Ca2  dependence of GABA release. (A) Cl  current
transients (top) and increase in cell capacitance (middle) elicited
by an increase in [Ca2 ]i (bottom) produced by photorelease from
caged Ca2  preloaded into the cell. The cell was held at  70 mV
and the time of photoliberation is indicated by the arrow (artifacts
in the capacitance trace caused by the Cl  current transients have
been removed). (B) Representative recordings of Cl  current
transients (indicated by arrows) from cells infused with pipette so-
lution containing 3  M (top) or 25  M (bottom) free Ca2 .199 Braun et al.
 M [Ca2 ]i. Again, the number of GABA-triggered cur-
rents is much less than expected if they resulted from exo-
cytosis of LDCVs. Using a conversion factor of 3.4 fF/
LDCV (as predicted from the vesicle diameter estab-
lished by electron microscopy), the rate of capacitance
increase observed at 25  M Ca2  corresponds to  200
granules/min, 10-fold higher than the number of
GABA-dependent current transients actually observed.
GABA Release Depends on Voltage-dependent Ca2  Inﬂux
To verify that GABA release is triggered by Ca2  inﬂux
through voltage-gated Ca2  channels in the plasma
membrane, trains of depolarizations were applied be-
fore and after addition of 10  M Cd2  to the extracellu-
lar solution (Fig. 7 A). It is evident that this broad-spec-
trum inhibitor of voltage-gated Ca2  channels abol-
ished GABA release (n   3). Thus, exocytosis of the
GABA-containing vesicles is secondary to Ca2  inﬂux
and not to membrane depolarization as such. We next
determined the voltage dependence of GABA release.
As shown in Fig. 7 B, no GABA was released when the
depolarization went to  50 mV. Depolarizations to
 40 mV and beyond elicited release of GABA, which
was maximal at  20 mV. When the pulses went above
 20 mV, a secondary reduction was observed because
of the reduced driving force for Ca2  into the  -cell.
This voltage dependence strongly resembled that of
the Ca2  current and virtually superimposed that of
exocytosis monitored as increases in cell capacitance.
Modulation of GABA Release by cAMP
Insulin secretion is stimulated by agents increasing in-
tracellular cAMP (Ämmälä et al., 1993). The involve-
ment of the cAMP-/protein kinase A–dependent path-
way in GABA exocytosis was studied by applying trains
of depolarizations from  70 to 0 mV before and after
addition of the adenylate cyclase activator forskolin (2
 M; Fig. 8 A). The results of 10 individual experiments
are summarized in Fig. 8 B. On average, forskolin in-
creased GABA release by 78%. In the same experi-
ments, the capacitance increase elicited by the depolar-
izations was augmented by forskolin by 49% (Fig. 8 C).
Thus, release of SLMVs and LDCVs exhibit a number
of similarities in terms of voltage and Ca2  dependence
and modulation by second messenger systems.
DISCUSSION
Like neurons and other endocrine cells (Bauerfeind et
al., 1993; Moriyama et al., 2000), pancreatic  -cells con-
tain two types of vesicles: LDCVs containing insulin and
SLMVs (Reetz et al., 1991). The function of the SLMVs
in the  -cell is unclear and it even remains to be un-
equivocally established that they are capable of under-
going regulated exocytosis. Here we describe a novel
system to detect the release of GABA at the single-vesi-
cle level with millisecond resolution by overexpression
of ionotropic GABAA receptors as autoreceptors for
Figure 7. Depolarization-evoked GABA release requires Ca2 -
inﬂux through voltage-gated Ca2 -channels. (A) Current responses
elicited by a train of ten 500-ms depolarizations from  70 to 0 mV
before (top) and after (bottom) addition of CdCl2 (10  M) to the
bath solution. (B) Cl  current transients (open circles), capaci-
tance increase ( Cm; ﬁlled circles), and peak Ca2  current (ICa;
squares) triggered by 500-ms depolarizations from  70 mV to the
indicated potentials. All data points correspond to average   SEM
from 8–35 experiments. Note that there is an  20 mV difference
in the liquid junction potential between the intracellular solution
used in this series of experiments and those used in most other ex-
periments. Thus, the voltage experienced by the cells during de-
polarization to 0 mV in Figs. 5, A and B, and 7 A is comparable to
 20 mV in this series of experiments.200 GABA Exocytosis in Pancreatic  -cells
neurotransmitter release (Hollins and Ikeda, 1997;
Whim and Moss, 2001). We show that GABA is released
by regulated exocytosis evoked by Ca2  inﬂux through
voltage-gated Ca2  channels.
Properties of Quantal GABA Release in Rat  -cells
The amount of GABA release detected varied substan-
tially from cell to cell. In good preparations, quantal re-
lease of GABA was observed in  50% of  -cells infused
with  3  M free Ca2 . Apart from variable levels of
GABAA receptor expression and exocytotic responses,
the failure to detect exocytotic release of GABA in the
remaining 50% of cells can be attributed to the variabil-
ity of cellular GABA content. Indeed, some isolated
 -cells exhibited only weak GABA immunoreactivity af-
ter 24 h of culture (Fig. 1 C). In addition to differences
in GAD65 expression, it has been reported that  -cells
lose  70% of biochemically determined GABA after
24 h of culture as compared with intact islets (Winnock
et al., 2002).
In some experiments with high release rates, e.g.,
during trains of voltage-clamp depolarizations (Figs. 5
A and 7 A), signiﬁcant overlap of the GABA-induced
current transients was observed, impeding the determi-
nation of the number of release events by direct count-
ing. In these experiments we estimated the frequency
of exocytotic events by measuring the total charge of
the GABA-induced current and dividing it through the
charge of an average event from the same experiment.
However, in most experiments, especially those involv-
ing infusion of the cells with Ca2 -containing solutions
(Figs. 3, 4, and 6 B), the great majority of the current
transients appeared well separated. This also reﬂects
the  5–10-fold lower release rates for GABA-contain-
ing vesicles compared with that expected for the re-
lease of insulin-containing LDCVs estimated by the ca-
pacitance measurements. Quantiﬁcation of the exocy-
totic events therefore did not seem to pose a general
problem for data analysis. Collectively, these observa-
tions suggest that although the SLMVs are capable of
undergoing exocytosis, the frequency of these events is
considerably lower than that of the LDCVs.
Analysis of the kinetics of the release events as well as
the amplitude distribution (Fig. 4, B–D) indicates that
they result from the exocytosis of a single population of
vesicles. If GABA were released by both exocytosis of
the LDCVs and SLMVs, then the rise time (t10–90%) as
well as half-widths would have been expected to vary
with the current amplitude, as has previously been
shown for serotonin release in Retzius neurons (Bruns
et al., 2000).
By mathematical modelling of experimentally ob-
tained current transients, we estimated that the average
intravesicular concentration of GABA is  0.9 M. This is
similar to the neurotransmitter concentration in other
vesicles (Travis and Wightman, 1998). The ﬁtting of
our model to experimental data also revealed that the
diffusion rate of GABA out of vesicles into the extracel-
lular space should be considerably slower than the rate
of its dispersion in the surrounding medium. If the dif-
fusion coefﬁcient for GABA within a vesicle was taken
to be equal to that in free solution (600  m s 1; Jayaraman
et al., 1999), then only very rapidly rising (t10–90%  
1 ms) and narrow (half-width:  1 ms) current spikes
were obtained in our calculations. Since these re-
sponses differ signiﬁcantly from those experimentally
observed, we propose that SLMVs in pancreatic  -cells,
by analogy to other neurotransmitter-containing vesi-
cles, contain a poly-electrolyte matrix that considerably
decreases the diffusion coefﬁcient of GABA. In accor-
dance with values obtained experimentally for cate-
Figure 8. cAMP stimulation of GABA exocytosis. (A) Cl  current
transients elicited by trains of 500-ms depolarizations before (top)
and 2 min after (bottom) addition of forskolin (2  M) to the bath
solution. (B) Histogram summarizing the GABA release events
elicited per train under control conditions and after stimulation
with forskolin. (C) As in B but instead showing the total increase in
cell capacitance ( Cm) elicited by the train. In B and C, the data
are mean values   SEM of 10 experiments.201 Braun et al.
cholamines in chromafﬁn cells (Amatore et al., 2000),
we therefore assumed a 100-fold reduced intravesicular
diffusion coefﬁcient for GABA molecules (6  m s 1).
Even with the reduced diffusion coefﬁcient, the cal-
culated spike still rose faster than expected from the
experimental data. We attribute this discrepancy to the
ﬁxed geometry of the fusion pore in our model (i.e.,
the fusion pore is taken to instantly dilate to its ﬁnal
size in the model). The slower time course we observe
experimentally indicates that the opening and forma-
tion of a fusion pore takes a certain time and during
the initial stages of a fusion event the release of GABA
is hindered by the small size of the pore.
In a vesicle with a diameter of 90 nm, the GABA con-
centration of 0.9 M results in an intravesicular GABA
content of 0.36 amol. Since a rat  -cell contains  3,500
SLMVs, the total vesicular pool of GABA amounts to
 1.25 fmol/cell or  6% of the total GABA content (21
pmol per 1,000 cells in intact rat islets; Winnock et al.,
2002). Thus, the bulk of the  -cell GABA resides in the
extravesicular space including the cytoplasm. Impor-
tantly, GABA is excluded from the insulin-containing
granules and measured GABA immunoreactivity within
these organelles was  20% of the average cellular con-
centration (Fig. 1 D).
SLMVs Belong to Functional Pools that Vary with Regard to 
Release Competence
During trains of depolarizing pulses, there was a pro-
gressive  75% decline of the GABA release probability
(Fig. 5, A and B). Release was restored when the same
stimulus was applied again after 2 min latency. The de-
cline in release probability could not be explained by a
corresponding reduction of Ca2 -inﬂux, which was only
reduced by 23%. In mouse  -cells, such small decreases
in Ca2  entry only marginally affect exocytosis (Ren-
ström et al., 1996). These observations instead suggest
that the GABA-containing vesicles, like insulin-contain-
ing LDCVs (Rorsman et al., 2000), are organized in dis-
tinct pools with different release kinetics. A limited
number of vesicles are immediately available for release
(“readily releasable pool”, RRP), representing most of
the exocytotic events during the ﬁrst pulses of the depo-
larization series. This RRP is reﬁlled from a larger re-
serve pool of vesicles that have to undergo preparatory
steps before being released, therefore displaying slower
release kinetics. It appears that a train of ten 500-ms de-
polarizations is sufﬁcient to fully deplete the RRP.
Exocytosis of SLMVs Contributes Marginally to Observed 
Capacitance Increase
It has been proposed that exocytosis of SLMVs consti-
tutes a sizeable fraction of the capacitance response in
 -cells (Takahashi et al., 1997). Comparison of the ca-
pacitance changes with the number of GABA release
events with knowledge about the diameters of the
SLMVs and LDCVs enabled us to determine how much
of the observed capacitance increase is attributable to
the exocytosis of the SLMVs. We thereby estimate that
release of the SLMVs typically accounts for 1–2% of the
observed capacitance increase. Thus, capacitance mea-
surements provide a good estimate of insulin granule
exocytosis.
Having access to two techniques allowing us to distin-
guish between exocytosis of SLMVs and LDCVs en-
abled us to compare the properties of the two pathways
of release. In general, exocytosis of the two types of ves-
icles exhibited similar regulation. This is in agreement
with comparative measurements of the release of ace-
tylcholine-containing SLMVs and catecholamine-stor-
ing LDCVs in phaeochromocytoma cells (Nishiki et al.,
1997) and with studies on glutamate secretion from pi-
nealocytes (Moriyama et al., 2000). It is worthy of note
that none of these studies provided any evidence for a
major difference in the release kinetics of SLMVs and
LDCVs (Fig. 5 A). In experiments involving dialysis of
the cytosol with stimulating Ca2  concentrations (Fig. 6
B), increasing the Ca2  concentration from 3 to 25  M
had a similar effect on the release rates of LDCVs and
SLMVs. We acknowledge that these experiments can-
not be used to derive the true Ca2 -sensitivity of exocy-
tosis (whether seen as a capacitance increase or GABA-
transients) because the release-competent pool will be
quickly depleted and other processes (such as reﬁlling
of the pool by vesicle mobilization) will then be rate
limiting for exocytosis. Nevertheless, the similar effect
of increasing [Ca2 ]i on GABA release and exocytosis
measured as capacitance increase (which principally re-
ﬂects exocytosis of the LDCVs) suggests that release of
both types of vesicles may involve the same Ca2  sensors
(Sugita et al., 2002).
GABA Is Released by Depolarization to Physiological 
Membrane Potentials
The physiological stimulus for secretory activity of
 -cells is an elevation of blood glucose levels, which
triggers electrical activity of the cells. The direct investi-
gation of the glucose effect on GABA exocytosis is not
straightforward with our assay, because for recording of
the GABA-induced current events the membrane volt-
age has to be clamped. This precludes the develop-
ment of glucose-induced electrical activity. A theoreti-
cally feasible approach would be the measurement of
GABA-evoked “postsynaptic potentials” in the current-
clamp mode. However, the Cl  equilibrium potential in
 -cells ( 43 mV; unpublished data) is close to their
membrane potential during glucose-induced electrical
activity (which oscillates between  40 and  20 mV;
Antunes et al., 2000). Consequently, the GABA-induced
potentials will be small and therefore difﬁcult to iden-202 GABA Exocytosis in Pancreatic  -cells
tify among glucose-induced action potentials. Instead
we simulated glucose-induced electrical activity by ap-
plying trains of voltage-clamp depolarizations. Glucose-
induced action potentials in rat  -cells usually peak at
around  20 mV (Antunes et al., 2000). GABA release
was elicited by depolarizations to voltages above  50
mV and was maximally stimulated by depolarization to
 20 mV ( 15 mV after correction for liquid junction
potentials; Fig. 7 B). Moreover, the voltage dependence
of GABA exocytosis closely followed that of both Ca2 
inﬂux and capacitance increases (reﬂecting exocytosis
of insulin-containing LDCVs). Action potentials in rat
 -cells have a half-width of 150–200 ms (Antunes et al.,
2000). Although we applied depolarization pulses of
500 ms duration,  40% of the GABA current transients
were triggered during the ﬁrst 200 ms of the depolar-
ization pulses (unpublished data). Together, these data
strongly suggest that GABA secretion from  -cells is
also glucose-stimulated.
Studies on the effect of glucose on GABA secretion
from pancreatic islets or from insulin-secreting cell
lines have so far yielded conﬂicting results. While some
studies showed a stimulation of GABA secretion by glu-
cose (Ahnert-Hilger and Wiedenmann, 1992; Gaskins
et al., 1995), others reported an inhibition (Smismans
et al., 1997; Hayashi et al., 2003) or no effect (Naga-
matsu et al., 1999; Bustamante et al., 2001). All of these
studies have relied on the determination of the GABA
concentration in the cell supernatant by HPLC, enzy-
matic assays or with radioactive tracers, mostly with low
temporal resolution (up to 24-h measurement inter-
vals). Rat  -cells have been reported to release 0.4 amol
of GABA per second and cell regardless of the glucose
concentration (Smismans et al., 1997). Given that an
SLMV contains 0.36 amol of GABA (Fig. 4 E), the spon-
taneous release rate would correspond to 1 SLMV per
second and  -cell. This is only  10% of the exocytotic
rate that can maximally be attained during membrane
depolarization (ﬁve events during 500 ms; Fig. 5 A, in-
set), but still relatively high in comparison with the re-
lease rate observed in dialysis experiments (Fig. 6 B).
The amounts of GABA secreted over long periods are
thus likely to reﬂect processes other than exocytotic re-
lease of the neurotransmitter, e.g., passive transporter–
mediated leakage. This route of release may be affected
by variations of GAD activity and changes in GABA con-
tent of the cells rather than changes in the glucose con-
centration (Smismans et al., 1997). Nevertheless, it is
clear that GABA, at least for brief periods, can be re-
leased at rates much higher than indicated by the previ-
ous biochemical assays.
Physiological Role of Regulated Release of GABA in Islets
With a basal release rate equivalent to one vesicle per
second and  -cell which increases 5–10-fold during
electrical activity, it is clear that both the  -cell itself as
well as its neighbors will be exposed to biologically ac-
tive concentrations of GABA and quite high interstitial
levels of the neurotransmitter may be attained close to
the release sites. This highlights the possibility of GABA
exerting a paracrine role within the pancreatic islets.
Indeed, GABAA and GABAB receptors have been docu-
mented in pancreatic islet cells (Rorsman et al., 1989;
Brice et al., 2002) and our own unpublished data indi-
cate that release of endogenous GABA from rat  -cells
inhibits glucagon and insulin release by activation of
GABAA and GABAB receptors, respectively.
The concept that a substance released from the
 -cells regulates glucagon secretion from neighboring
 -cells is underscored by the recent observations of Ish-
ihara et al. (2003), who postulated that Zn2  coreleased
with insulin may inhibit glucagon secretion although
the mechanisms remain obscure. It is likely that several
mechanisms contribute to the glucose regulation of
glucagon release from the  -cells in vivo. It should also
be emphasized that not all regulation needs to be ex-
erted via paracrine signaling as even individual  -cells
and pure  -cell preparations retain the ability to re-
spond to glucose (Pipeleers et al., 1985; Johansson et
al., 1989).
Signiﬁcance to Diabetes
The ﬁnding that GABA-containing SLMVs undergo
exocytosis may ﬁnally be of signiﬁcance to the under-
standing of type 1 diabetes. It is tempting to speculate
that the selective destruction of the  -cells in type 1 dia-
betes, although the autoantigen GAD65 is expressed in
several other cells (Tillakaratne et al., 1995), is a conse-
quence of the functional signiﬁcance of GABAergic
processes within the islet and the high rate of SLMV
exocytosis. Intriguingly, pharmacological procedures
that hyperpolarize the  -cell and thus can be expected
to inhibit exocytosis of the SLMVs have been reported
to reduce GAD65 presentation and exert a  -cell pro-
tective action in type 1 diabetes (Karlsson et al., 2000).
In addition, altered paracrine signaling in the islet may
be a causative factor for the increase in glucagon secre-
tion that contributes to the metabolic disturbances in
both type 1 and type 2 diabetes (Krentz and Nattrass,
1997; Shah et al., 2000).
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